Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v8-EN | Version v5-EN | |
|---|---|---|
| Language | English | English |
| Date Updated | 2021-06-24 | 2021-04-17 |
| Drug Identification Number | 02278057 | 02278057 |
| Brand name | VOLUVEN | VOLUVEN |
| Common or Proper name | Voluven® (6% hydroxyethyl starch 130/0.4 in 0.9% sodium chloride injection) 500 mL | Voluven® (6% hydroxyethyl starch 130/0.4 in 0.9% sodium chloride injection) 500 mL |
| Company Name | FRESENIUS KABI CANADA LTD | FRESENIUS KABI CANADA LTD |
| Ingredients | HYDROXYETHYL STARCH 130/0.4 | HYDROXYETHYL STARCH 130/0.4 |
| Strength(s) | 6% | 6% |
| Dosage form(s) | SOLUTION | SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS | INTRAVENOUS INTRAVENOUS |
| Packaging size | 500 mL | 500 mL |
| ATC code | B05AA | B05AA |
| ATC description | BLOOD AND RELATED PRODUCTS | BLOOD AND RELATED PRODUCTS |
| Reason for shortage | Disruption of the manufacture of the drug. | Disruption of the manufacture of the drug. |
| Anticipated start date | 2021-04-16 | 2021-04-16 |
| Actual start date | 2021-04-16 | 2021-04-16 |
| Estimated end date | 2021-07-01 | 2021-07-01 |
| Actual end date | 2021-06-23 | |
| Shortage status | Resolved | Actual shortage |
| Tier 3 Status | No | No |
| Company comments | Fresenius Kabi Canada Ltd. regrets to advise that due to a production delay, we will be encountering a supply interruption on our Voluven® 500 mL effective immediately until July 1st, 2021. Please note that our remaining inventory is short-dated with less than 1 month dating, and expires on April 30, 2021. Our Voluven® 250 mL and Volulyte® 500 mL formats are available for substitution. | Fresenius Kabi Canada Ltd. regrets to advise that due to a production delay, we will be encountering a supply interruption on our Voluven® 500 mL effective immediately until July 1st, 2021. Please note that our remaining inventory is short-dated with less than 1 month dating, and expires on April 30, 2021. Our Voluven® 250 mL and Volulyte® 500 mL formats are available for substitution. |
| Health Canada comments |